Lista de obras - A Tosetto - Dominio Público Uruguay

A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

scientific article published on 07 April 2020

Bleeders, bleeding rates, and bleeding score ⬇️

artículo científico publicado el 1 de junio de 2013

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment

scientific article published on 01 August 2011

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

scientific article published on 27 November 2020

Bleeding symptoms in patients diagnosed as type 3 Von Willebrand Disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study

scientific article published on 07 May 2020

Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance ⬇️

artículo científico publicado el 25 de enero de 2011

D-dimer testing to determine the duration of anticoagulation therapy

artículo científico publicado en 2006

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

scientific article published on 05 November 2019

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism

scientific article published on 25 May 2020

Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients ⬇️

artículo científico publicado el 1 de abril de 2012

External validation of the DASH prediction rule: a retrospective cohort study.

artículo científico publicado en 2017

Fibrin glue from single-donation autologous plasmapheresis

artículo científico publicado el 1 de septiembre de 1992

Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A

artículo científico publicado en 2019

How I treat type 2 variant forms of von Willebrand disease.

artículo científico publicado en 2014

Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study ⬇️

artículo científico publicado el 1 de octubre de 1997

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme

artículo científico publicado en 2018

Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A? ⬇️

artículo científico publicado el 4 de marzo de 2011

Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation ⬇️

artículo científico publicado el 1 de abril de 1998

Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences

artículo científico publicado en 2013

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results ⬇️

artículo científico publicado el 1 de octubre de 2012

Platelet von willebrand factor abnormalities in myeloproliferative syndromes ⬇️

artículo científico publicado el 1 de agosto de 1995

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

artículo científico publicado en 2011

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

artículo científico publicado en 2018

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.

artículo científico publicado en 2015

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

artículo científico publicado en 2018

The American College of Chest Physicians score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism-Response

artículo científico publicado en 2019

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

artículo científico publicado en 2015

The Role of Bleeding History and Clinical Markers for the Correct Diagnosis of VWD ⬇️

artículo científico publicado el 12 de julio de 2013

The VITA Project: C677T mutation in the methylene‐tetrahydrofolate reductase gene and risk of venous thromboembolism ⬇️

artículo científico publicado el 1 de junio de 1997

The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study

scientific article published on 15 July 2019

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure

scientific article published on 30 October 2020

Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study

artículo científico publicado en 2009

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study

artículo científico publicado en 2009

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study ⬇️

artículo científico publicado el 27 de junio de 2012

Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC

artículo científico publicado en 2019

Lista de obras de A Tosetto

A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Bleeders, bleeding rates, and bleeding score ⬇️

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

Bleeding symptoms in patients diagnosed as type 3 Von Willebrand Disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study

Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance ⬇️

D-dimer testing to determine the duration of anticoagulation therapy

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism

Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients ⬇️

External validation of the DASH prediction rule: a retrospective cohort study.

Fibrin glue from single-donation autologous plasmapheresis

Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A

How I treat type 2 variant forms of von Willebrand disease.

Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study ⬇️

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme

Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A? ⬇️

Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation ⬇️

Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results ⬇️

Platelet von willebrand factor abnormalities in myeloproliferative syndromes ⬇️

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

The American College of Chest Physicians score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism-Response

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

The Role of Bleeding History and Clinical Markers for the Correct Diagnosis of VWD ⬇️

The VITA Project: C677T mutation in the methylene‐tetrahydrofolate reductase gene and risk of venous thromboembolism ⬇️

The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure

Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study ⬇️

Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC